Alpha Cognition Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALPHA COGNITION, and what generic alternatives to ALPHA COGNITION drugs are available?
ALPHA COGNITION has one approved drug.
There are two US patents protecting ALPHA COGNITION drugs.
There are twenty patent family members on ALPHA COGNITION drugs in seventeen countries.
Drugs and US Patents for Alpha Cognition
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-003 | Jul 26, 2024 | RX | Yes | No | 9,763,953 | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-001 | Jul 26, 2024 | RX | Yes | Yes | 9,763,953 | ⤷ Sign Up | ⤷ Sign Up | ||||
Alpha Cognition | ZUNVEYL | benzgalantamine gluconate | TABLET, DELAYED RELEASE;ORAL | 218549-002 | Jul 26, 2024 | RX | Yes | No | 11,795,176 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Alpha Cognition Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2023008276 | ⤷ Sign Up |
South Korea | 20230131220 | ⤷ Sign Up |
European Patent Office | 4277907 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.